Newstral
Article
The Hindu on 2020-05-25 19:00
Coronavirus | WHO suspends clinical trials of hydroxychloroquine over safety concerns
Related news
- WHO suspends hydroxychloroquine trials amid safety concernsNew York Post
- WHO stops hydroxychloroquine trials over safety concernsmonitor.co.ug
- Coronavirus | Hydroxychloroquine clinical trials will resume, says WHOThe Hindu
- MNews24.com | WHO suspends trial of hydroxychloroquine as Covid-19 treatment over safety concernsm.news24.com
- WHO Pauses Hydroxychloroquine Study Amid Concerns Over Drug’s SafetyForbes
- France bans hydroxychloroquine to treat COVID-19 amid safety concernstribuneonlineng.com
- WHO suspends trials of hydroxychloroquine as virus treatmenttimesofmalta.com
- WHO suspends clinical trials of hydroxychloriquineisraelnationalnews.com
- MHydroxychloroquine sparks renewed controversy but clinical trials are pushing aheadmarketwatch.com
- WHO pauses hydroxychloroquine study due to safety concernsSan Jose Mercury News
- WHO Pauses Hydroxychloroquine Coronavirus Trial Over Safety Concernsslate.com
- WHO suspends coronavirus trial of hydroxychloroquine drug taken by Trumptimesofisrael.com
- BWHO suspends hydroxychloroquine testsbbc.co.uk
- IWHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concernsin.reuters.com
- Hydroxychloroquine maker stops enrolling COVID-19 patients in trialsSan Jose Mercury News
- Doubt looms over hydroxychloroquine study that halted global trialsArs Technica
- Brazil suspends Bharat Biotech's Covaxin clinical trialsThe Hindu
- Covid: WHO suspends hydroxychloroquine trialThe Times of India
- World Health Organization temporarily halts hydroxychloroquine trialsCBC
- Study raising concerns about using hydroxychloroquine to treat virus retractedtimesofisrael.com